3-hydroxyephedrine has been researched along with Autoimmune Diabetes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kirkwood, I; Larkin, D; Marinescu, V; Pop-Busui, R; Raffel, DM; Schmid, H; Schroeder, J; Stevens, MJ; Yamada, E | 1 |
Allman, KC; Greene, DA; Hutchins, GD; Schwaiger, M; Stevens, MJ; Wieland, DM; Wolfe, ER | 1 |
2 other study(ies) available for 3-hydroxyephedrine and Autoimmune Diabetes
Article | Year |
---|---|
Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.
Topics: Adenosine; Adult; Autonomic Nervous System Diseases; C-Reactive Protein; Carbon Radioisotopes; Contrast Media; Coronary Circulation; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diastole; Ephedrine; Female; Heart; Heart Conduction System; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oxidative Stress; Vasoconstriction; Ventricular Dysfunction, Left; von Willebrand Factor | 2004 |
Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Blood Flow Velocity; Carbon Radioisotopes; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Ephedrine; Female; Heart Diseases; Humans; Male; Middle Aged; Sensitivity and Specificity; Severity of Illness Index; Sympathetic Nervous System; Tomography, Emission-Computed | 1993 |